Adachi, K., & Tamada, K. (2015). Immune checkpoint blockade opens an avenue of cancer immunotherapy with a potent clinical efficacy. Cancer Science, 106(8), 945–50. http://doi.org/10.1111/cas.12695
Addgene. (2015). Viral Vectors - An Introduction. In Plasmids 101: A Desktop Resource (2nd ed., pp. 64–73). Addgene. Retrieved from http://info.addgene.org/download-addgenes-ebook-plasmids-101-1st-edition
American Type Culture Collection (ATCC). (2014). 293T [HEK 293T] ATCC ® CRL-3216TM Homo sapiens kidney. Retrieved May 12, 2016, from http://www.lgcstandards-atcc.org/Products/All/CRL-3216.aspx
Argyros, O., Wong, S.-P., & Harbottle, R. P. (2011). Non-viral episomal modification of cells using S/MAR elements. Expert Opinion on Biological Therapy, 11(9), 1177–91. http://doi.org/10.1517/14712598.2011.582035
Beijerinck, M. W. (1898). Concerning a contagium vivum fluidum as cause of the spot disease of tobacco leaves. Phytopathological Classics, 7.
Berg, J. M., Tymoczko, J. L., & Stryer, L. (2002). Transcription Is Catalyzed by RNA Polymerase. W H Freeman. Retrieved from http://www.ncbi.nlm.nih.gov/books/NBK22546/
Bonehill, A., Van Nuffel, A. M. T., Corthals, J., Tuyaerts, S., Heirman, C., François, V., … Thielemans, K. (2009). Single-step antigen loading and activation of dendritic cells by mRNA electroporation for the purpose of therapeutic vaccination in melanoma patients. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 15(10), 3366–75. http://doi.org/10.1158/1078-0432.CCR-08-2982
Breckpot, K., Dullaers, M., Bonehill, A., van Meirvenne, S., Heirman, C., de Greef, C., … Thielemans, K. (2003). Lentivirally transduced dendritic cells as a tool for cancer immunotherapy. The Journal of Gene Medicine, 5(8), 654–67. http://doi.org/10.1002/jgm.400
Breckpot, K., Emeagi, P., Dullaers, M., Michiels, A., Heirman, C., & Thielemans, K. (2007). Activation of immature monocyte-derived dendritic cells after transduction with high doses of lentiviral vectors. Human Gene Therapy, 18(6), 536–46. http://doi.org/10.1089/hum.2007.006
Breckpot, K., Escors, D., Arce, F., Lopes, L., Karwacz, K., Van Lint, S., … Collins, M. (2010). HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7. Journal of Virology, 84(11), 5627–36. http://doi.org/10.1128/JVI.00014-10
Bukrinsky, M. I., Haggerty, S., Dempsey, M. P., Sharova, N., Adzhubel, A., Spitz, L., … Stevenson, M. (1993). A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells. Nature, 365(6447), 666–9. http://doi.org/10.1038/365666a0
Charles A Janeway, J., Travers, P., Walport, M., & Shlomchik, M. J. (2001). The course of the adaptive response to infection. Garland Science. Retrieved from http://www.ncbi.nlm.nih.gov/books/NBK27125/
Compton, A. A., Malik, H. S., & Emerman, M. (2013). Host gene evolution traces the evolutionary history of ancient primate lentiviruses. Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences, 368(1626), 20120496. http://doi.org/10.1098/rstb.2012.0496
Cronin, J., Zhang, X.-Y., & Reiser, J. (2005). Altering the tropism of lentiviral vectors through pseudotyping. Current Gene Therapy, 5(4), 387–98. Retrieved from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1368960&tool=…
D’Herelle, F. (1917). Sur un microbe invisible antagoniste des bacilles dysentériques. Comptes rendus Acad Sci Paris.
Dimmock, N. J., Easton, A. J., & Leppard, K. N. (2007). Introduction to Modern Virology (6th ed.). Wiley-Blackwell.
Dufait, I., Liechtenstein, T., Lanna, A., Bricogne, C., Laranga, R., Padella, A., … Escors, D. (2012). Retroviral and lentiviral vectors for the induction of immunological tolerance. Scientifica, 2012. http://doi.org/10.6064/2012/694137
Dullaers, M., Breckpot, K., Van Meirvenne, S., Bonehill, A., Tuyaerts, S., Michiels, A., … Thielemans, K. (2004). Side-by-side comparison of lentivirally transduced and mRNA-electroporated dendritic cells: implications for cancer immunotherapy protocols. Molecular Therapy : The Journal of the American Society of Gene Therapy, 10(4), 768–79. http://doi.org/10.1016/j.ymthe.2004.07.017
Durand, S., & Cimarelli, A. (2011). The inside out of lentiviral vectors. Viruses, 3(2), 132–59. http://doi.org/10.3390/v3020132
Eggermont, L. J., Paulis, L. E., Tel, J., & Figdor, C. G. (2014). Towards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells. Trends in Biotechnology, 32(9), 456–65. http://doi.org/10.1016/j.tibtech.2014.06.007
Emeagi, P. U., Van Lint, S., Goyvaerts, C., Maenhout, S., Cauwels, A., McNeish, I. A., … Breckpot, K. (2012). Proinflammatory characteristics of SMAC/DIABLO-induced cell death in antitumor therapy. Cancer Research, 72(6), 1342–52. http://doi.org/10.1158/0008-5472.CAN-11-2400
Friedmann, T., & Roblin, R. (1972). Gene therapy for human genetic disease? Science (New York, N.Y.), 175(4025), 949–55. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/5061866
Garmory, H. S., Brown, K. A., & Titball, R. W. (2003). DNA vaccines: improving expression of antigens. Genetic Vaccines and Therapy, 1(1), 2. http://doi.org/10.1186/1479-0556-1-2
Goyvaerts, C., Bricogne, C., Escors, D., & Breckpot, K. (2012). Targeted Lentiviral Vectors : Current Applications and Future Potential. In F. M. Molina (Ed.), Gene Therapy (2nd ed.). InTech. http://doi.org/10.5772/52770
Goyvaerts, C., Broos, K., Escors, D., Heirman, C., Raes, G., De Baetselier, P., … Breckpot, K. (2015). The transduction pattern of IL-12-encoding lentiviral vectors shapes the immunological outcome. European Journal of Immunology, 45(12), 3351–61. http://doi.org/10.1002/eji.201545559
Goyvaerts, C., Kurt, D. G., Van Lint, S., Heirman, C., Van Ginderachter, J. A., De Baetselier, P., … Breckpot, K. (2014). Immunogenicity of targeted lentivectors. Oncotarget, 5(3), 704–15. http://doi.org/10.18632/oncotarget.1680
Guan, B., Wang, T.-L., & Shih, I.-M. (2011). ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers. Cancer Research, 71(21), 6718–27. http://doi.org/10.1158/0008-5472.CAN-11-1562
Ivanovsky, D. (1892). Concerning the mosaic disease of the tobacco plant. Phytopathological Classics, 7, 67–70.
Ivanovsky, D. (1903). Ueber die Mosaikkrankheit der Tabakspflanze. (Vol. 13, pp. 1–41).
Lewis, P. F., & Emerman, M. (1994). Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus. Journal of Virology, 68(1), 510–6. Retrieved from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=236313&tool=p…
Lumniczky, K., & Sáfrány, G. (2006). Cancer gene therapy: combination with radiation therapy and the role of bystander cell killing in the anti-tumor effect. Pathology Oncology Research : POR, 12(2), 118–24. http://doi.org/PAOR.2006.12.2.0118
Lustig, A., & Levine, A. J. (1992). One hundred years of virology. Journal of Virology, 66(8), 4629–31. Retrieved from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=241285&tool=p…
Mahon, M. (2011). Vectors bicistronically linking a gene of interest to the SV40 large T antigen in combination with the SV40 origin of replication enhance transient protein expression and luciferase reporter activity. BioTechniques, 51(2), 119–28. http://doi.org/10.2144/000113720
Mankertz, A., Domingo, M., Folch, J. M., LeCann, P., Jestin, A., Segalés, J., … Soike, D. (2000). Characterisation of PCV-2 isolates from Spain, Germany and France. Virus Research, 66(1), 65–77. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/10653918
Mann, R., Mulligan, R. C., & Baltimore, D. (1983). Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell, 33(1), 153–9. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/6678608
Mátrai, J., Chuah, M. K. L., & VandenDriessche, T. (2010). Recent advances in lentiviral vector development and applications. Molecular Therapy : The Journal of the American Society of Gene Therapy, 18(3), 477–90. http://doi.org/10.1038/mt.2009.319
Movahedi, K., Schoonooghe, S., Laoui, D., Houbracken, I., Waelput, W., Breckpot, K., … Van Ginderachter, J. A. (2012). Nanobody-based targeting of the macrophage mannose receptor for effective in vivo imaging of tumor-associated macrophages. Cancer Research, 72(16), 4165–77. http://doi.org/10.1158/0008-5472.CAN-11-2994
Odegard, J. M., Kelley-Clarke, B., Tareen, S. U., Campbell, D. J., Flynn, P. A., Nicolai, C. J., … Robbins, S. H. (2015). Virological and preclinical characterization of a dendritic cell targeting, integration-deficient lentiviral vector for cancer immunotherapy. Journal of Immunotherapy (Hagerstown, Md. : 1997), 38(2), 41–53. http://doi.org/10.1097/CJI.0000000000000067
Pauwels, K., Gijsbers, R., Toelen, J., Schambach, A., Willard-Gallo, K., Verheust, C., … Herman, P. (2009). State-of-the-art lentiviral vectors for research use: risk assessment and biosafety recommendations. Current Gene Therapy, 9(6), 459–74. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/20021330
Philippe, N., Legendre, M., Doutre, G., Couté, Y., Poirot, O., Lescot, M., … Abergel, C. (2013). Pandoraviruses: amoeba viruses with genomes up to 2.5 Mb reaching that of parasitic eukaryotes. Science (New York, N.Y.), 341(6143), 281–6. http://doi.org/10.1126/science.1239181
Pincha, M., Sundarasetty, B. S., Salguero, G., Gutzmer, R., Garritsen, H., Macke, L., … Stripecke, R. (2012). Identity, potency, in vivo viability, and scaling up production of lentiviral vector-induced dendritic cells for melanoma immunotherapy. Human Gene Therapy Methods, 23(1), 38–55. http://doi.org/10.1089/hgtb.2011.170
Seelamgari, A., Maddukuri, A., Berro, R., de la Fuente, C., Kehn, K., Deng, L., … Kashanchi, F. (2004). Role of viral regulatory and accessory proteins in HIV-1 replication. Frontiers in Bioscience : A Journal and Virtual Library, 9, 2388–413. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/15353294
Springgate, C. F., Battula, N., & Loeb, L. A. (1973). Infidelity of DNA synthesis by reverse transcriptase. Biochemical and Biophysical Research Communications, 52(2), 401–6. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/4123058
Svarovskaia, E. S., Cheslock, S. R., Zhang, W.-H., Hu, W.-S., & Pathak, V. K. (2003). Retroviral mutation rates and reverse transcriptase fidelity. Frontiers in Bioscience : A Journal and Virtual Library, 8, d117–34. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/12456349
Tareen, S. U., Nicolai, C. J., Campbell, D. J., Flynn, P. A., Slough, M. M., Vin, C. D., … Robbins, S. H. (2013). A Rev-Independent gag/pol Eliminates Detectable psi-gag Recombination in Lentiviral Vectors. BioResearch Open Access, 2(6), 421–430. http://doi.org/10.1089/biores.2013.0037
Vogt, V. (1997). Retroviral Virions and Genomes. Cold Spring Harbor Laboratory Press. Retrieved from http://www.ncbi.nlm.nih.gov/books/NBK19454/
Wanisch, K., & Yáñez-Muñoz, R. J. (2009). Integration-deficient lentiviral vectors: a slow coming of age. Molecular Therapy : The Journal of the American Society of Gene Therapy, 17(8), 1316–32. http://doi.org/10.1038/mt.2009.122
Watanabe, S., & Temin, H. M. (1983). Construction of a helper cell line for avian reticuloendotheliosis virus cloning vectors. Molecular and Cellular Biology, 3(12), 2241–9. Retrieved from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=370095&tool=p…
Wiley Online Library. (2015). Retrieved March 1, 2016, from http://www.wiley.com/legacy/wileychi/genmed/clinical/
Zufferey, R., Dull, T., Mandel, R. J., Bukovsky, A., Quiroz, D., Naldini, L., & Trono, D. (1998). Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. Journal of Virology, 72(12), 9873–80. Retrieved from http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=110499&tool=p…
Zwolińska, K. (2006). [Retroviruses-derived sequences in the human genome. Human endogenous retroviruses (HERVs)]. Postȩpy Higieny I Medycyny Doświadczalnej (Online), 60, 637–52. Retrieved from http://www.ncbi.nlm.nih.gov/pubmed/17199106